Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
Completed · Phase 2
Conditions studied: Smoking Cessation, Tobacco Use Disorder
In brief
Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
Key facts
- Study ID
- NCT00158171
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 128
- Starts
- 2002-04-01
- Expected to finish
- 2004-05-01
- Last updated by the study team
- 2017-01-10
Who can join
Age: 13 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- At least 6 months of daily cigarette smoking
- No use of other tobacco products
- Motivated to reduce or quit smoking
- Not currently using medications to quit smoking
- Agree to use an effective form of contraception throughout the study
You may not qualify if…
- People for whom use of nicotine replacement therapy or bupropion is medically inadvisable
- History of alcohol or drug abuse within 6 months of enrollment
- History of emotional problems (as assessed by the Adolescent Symptoms Inventory) within 6 months prior to enrollment
- Currently on an unstable dose of psychoactive medications
- Currently taking medications that may react with one of the treatment medications
- Pregnant
Where it is running
- University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.